About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

International Ovarian Tumour Analysis (IOTA) Phase 5

NCT01698632·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

KU Leuven

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Any woman at least 18 years old with an adnexal mass.
Any mass with benign ultrasound morphology may be suitable for conservative management.
Pregnant patients can be included, but their data will be analysed separately.

You may not be if

Any cyst with features of malignancy is excluded from the conservative management
The denial or withdrawal of oral informed consent

The record

StatusUnknown

PhaseNo phase

Taking part15,000

StartedJan 2012

UpdatedApr 14, 2020

Conditions

Adnexal Masses Ovarian Cysts Ovarian Tumors

Where1

USF Health South Tampa Center for Advanced Healthcare
Tampa, Florida, United States

Clareo Health | International Ovarian Tumour Analysis (IOTA) Phase 5